Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer

L. Tamarkin, D. Danforth, A. Lichter, E. DeMoss, M. Cohen, B. Chabner, Marc E Lippman

Research output: Contribution to journalArticle

187 Citations (Scopus)

Abstract

Plasma melatonin concentrations were determined over a period of 24 hours in 20 women with clinical stage I or II breast cancer. In ten of the patients, whose tumors were estrogen receptor positive, the nocturnal increase in plasma melatonin was much lower than that observed in eight control subjects. Women with the lowest peak concentration of melatonin had tumors with the highest concentrations of estrogen receptors. A significant correlation was found between the peak plasma melatonin concentration and the tumor estrogen receptor concentration in 19 of the patients. These data suggest that low nocturnal melatonin concentrations may indicate the presence of estrogen receptor positive breast cancer and could conceivably have etiologic significance.

Original languageEnglish
Pages (from-to)1003-1005
Number of pages3
JournalScience
Volume216
Issue number4549
DOIs
StatePublished - Dec 1 1982
Externally publishedYes

Fingerprint

Melatonin
Estrogen Receptors
Breast Neoplasms
Neoplasms

ASJC Scopus subject areas

  • General

Cite this

Tamarkin, L., Danforth, D., Lichter, A., DeMoss, E., Cohen, M., Chabner, B., & Lippman, M. E. (1982). Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. Science, 216(4549), 1003-1005. https://doi.org/10.1126/science.7079745

Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. / Tamarkin, L.; Danforth, D.; Lichter, A.; DeMoss, E.; Cohen, M.; Chabner, B.; Lippman, Marc E.

In: Science, Vol. 216, No. 4549, 01.12.1982, p. 1003-1005.

Research output: Contribution to journalArticle

Tamarkin, L, Danforth, D, Lichter, A, DeMoss, E, Cohen, M, Chabner, B & Lippman, ME 1982, 'Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer', Science, vol. 216, no. 4549, pp. 1003-1005. https://doi.org/10.1126/science.7079745
Tamarkin L, Danforth D, Lichter A, DeMoss E, Cohen M, Chabner B et al. Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. Science. 1982 Dec 1;216(4549):1003-1005. https://doi.org/10.1126/science.7079745
Tamarkin, L. ; Danforth, D. ; Lichter, A. ; DeMoss, E. ; Cohen, M. ; Chabner, B. ; Lippman, Marc E. / Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. In: Science. 1982 ; Vol. 216, No. 4549. pp. 1003-1005.
@article{89774e89b02c4e8c819bd31fd08d72de,
title = "Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer",
abstract = "Plasma melatonin concentrations were determined over a period of 24 hours in 20 women with clinical stage I or II breast cancer. In ten of the patients, whose tumors were estrogen receptor positive, the nocturnal increase in plasma melatonin was much lower than that observed in eight control subjects. Women with the lowest peak concentration of melatonin had tumors with the highest concentrations of estrogen receptors. A significant correlation was found between the peak plasma melatonin concentration and the tumor estrogen receptor concentration in 19 of the patients. These data suggest that low nocturnal melatonin concentrations may indicate the presence of estrogen receptor positive breast cancer and could conceivably have etiologic significance.",
author = "L. Tamarkin and D. Danforth and A. Lichter and E. DeMoss and M. Cohen and B. Chabner and Lippman, {Marc E}",
year = "1982",
month = "12",
day = "1",
doi = "10.1126/science.7079745",
language = "English",
volume = "216",
pages = "1003--1005",
journal = "Science",
issn = "0036-8075",
publisher = "American Association for the Advancement of Science",
number = "4549",

}

TY - JOUR

T1 - Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer

AU - Tamarkin, L.

AU - Danforth, D.

AU - Lichter, A.

AU - DeMoss, E.

AU - Cohen, M.

AU - Chabner, B.

AU - Lippman, Marc E

PY - 1982/12/1

Y1 - 1982/12/1

N2 - Plasma melatonin concentrations were determined over a period of 24 hours in 20 women with clinical stage I or II breast cancer. In ten of the patients, whose tumors were estrogen receptor positive, the nocturnal increase in plasma melatonin was much lower than that observed in eight control subjects. Women with the lowest peak concentration of melatonin had tumors with the highest concentrations of estrogen receptors. A significant correlation was found between the peak plasma melatonin concentration and the tumor estrogen receptor concentration in 19 of the patients. These data suggest that low nocturnal melatonin concentrations may indicate the presence of estrogen receptor positive breast cancer and could conceivably have etiologic significance.

AB - Plasma melatonin concentrations were determined over a period of 24 hours in 20 women with clinical stage I or II breast cancer. In ten of the patients, whose tumors were estrogen receptor positive, the nocturnal increase in plasma melatonin was much lower than that observed in eight control subjects. Women with the lowest peak concentration of melatonin had tumors with the highest concentrations of estrogen receptors. A significant correlation was found between the peak plasma melatonin concentration and the tumor estrogen receptor concentration in 19 of the patients. These data suggest that low nocturnal melatonin concentrations may indicate the presence of estrogen receptor positive breast cancer and could conceivably have etiologic significance.

UR - http://www.scopus.com/inward/record.url?scp=0020319416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020319416&partnerID=8YFLogxK

U2 - 10.1126/science.7079745

DO - 10.1126/science.7079745

M3 - Article

C2 - 7079745

AN - SCOPUS:0020319416

VL - 216

SP - 1003

EP - 1005

JO - Science

JF - Science

SN - 0036-8075

IS - 4549

ER -